BioCentury | Aug 12, 2002
Clinical News

COP 201: Feasibility study

...company will use technology from Ostex International Inc. (OSTX, Seattle, Wash.) to track bone loss. Cennapharm Corp....
Items per page:
1 - 1 of 1
BioCentury | Aug 12, 2002
Clinical News

COP 201: Feasibility study

...company will use technology from Ostex International Inc. (OSTX, Seattle, Wash.) to track bone loss. Cennapharm Corp....
Items per page:
1 - 1 of 1